Myriad Genetics

NASDAQ: MYGN
$11.47
+$0.03 (+0.3%)
Closing price July 10, 2020
Not that many biotech and pharma companies were on the move Wednesday, but a few of the smaller caps made splash, while one giant company posted a massive loss.
The top analyst upgrades, downgrades and initiations seen on Monday morning include Arch Coal, Dow Chemical, Netflix, Mylan, Under Armour and United Technologies.
The broad markets are continuing to hit all-time highs as the market is shifting gears out of the earnings season. Despite all the positive sentiment in the market, quite a few companies still...
Does a rising tide lifts all boats? 24/7 Wall St. has tracked 28 stocks hitting 52-week lows on Wednesday, August 10, 2016.
24/7 Wall St. could not help but notice how many analysts on Wall Street have simply abandoned their old upside hopes for Myriad Genetics.
The top analyst upgrades, downgrades and initiations seen on Wednesday morning include Eldorado Gold, SLM, SunPower, Disney, Yelp and Myriad Genetics.
The top analyst upgrades, downgrades and initiations seen on Friday morning include Alphabet, Amazon, Dow Chemical, Ford, Gilead, Harley-Davidson and Western Digital.
Tuesday’s top analyst upgrades, downgrades and initiations include Amazon.com, Blackstone, FireEye, Myriad Genetics, Visa, CBOE, Hershey and Vail Resorts.
Tuesday's top analyst upgrades, downgrades and initiations include Apple, Bank of America, Canadian Solar, Garmin, Regions Financial and Euronav.
The analysts at Cowen have calculated the buys and sells in the NYSE Arca Biotechnology Index based on the holdings in the First Trust Biotechnology ETF.
In a new research report, Cowen analysts focus on three life science stocks that they think could beat current consensus earnings estimates.
Thursday's top analyst upgrades and downgrades include Apple, ASML, Charles Schwab, GoPro, Kraft Foods, Netflix and Red Hat.
Tuesday's top analyst upgrades and downgrades include AcelRx Pharmaceuticals, AECOM, Electronic Arts, Hewlett-Packard, Myriad Genetics and Urban Outfitters.
Myriad Genetics shares traded down as much as 16% Wednesday morning after the company lowered its fiscal-year guidance.
Wednesday's top analyst upgrades, downgrades and initiations include Coupons.com, Dean Foods, Hilton, Isis Pharma, National Oilwell Varco and Stratasys.